Bacteria and Bacterial Components as Natural Bio-Nanocarriers for Drug and Gene Delivery Systems in Cancer Therapy

• Published in: Pharmaceutics Vol. 15; no. 10; p. 2490
• Main Authors: Zong, Rui, Ruan, Hainan, Liu, Chanmin, Fan, Shaohua, Li, Jun
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.10.2023; MDPI
• Subjects: Bacteria; bacterial components; Bacterial infections; BCG; BCG vaccines; Biocompatibility; biomimetic nanoplatforms; Cancer; Cancer therapies; Clinical trials; Drug delivery systems; E coli; engineered strategies; Fibroblasts; gene therapy; Genetic aspects; Genetic engineering; Gram-positive bacteria; Health aspects; Homeopathy; Hypoxia; Immune system; Lipids; Listeria; Materia medica and therapeutics; Medical research; Metabolites; Metastasis; Nanomaterials; Nanoparticles; Nanotechnology; Permeability; Polyethylene glycol; Proteins; Review; Salmonella; Therapeutics; tumor targeting; Tumors; gene therapy; tumor targeting; bacteria; engineered strategies; bacterial components; biomimetic nanoplatforms
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics15102490

Bacteria and bacterial components possess multifunctional properties, making them attractive natural bio-nanocarriers for cancer diagnosis and targeted treatment. The inherent tropic and motile nature of bacteria allows them to grow and colonize in hypoxic tumor microenvironments more readily than conventional therapeutic agents and other nanomedicines. However, concerns over biosafety, limited antitumor efficiency, and unclear tumor-targeting mechanisms have restricted the clinical translation and application of natural bio-nanocarriers based on bacteria and bacterial components. Fortunately, bacterial therapies combined with engineering strategies and nanotechnology may be able to reverse a number of challenges for bacterial/bacterial component-based cancer biotherapies. Meanwhile, the combined strategies tend to enhance the versatility of bionanoplasmic nanoplatforms to improve biosafety and inhibit tumorigenesis and metastasis. This review summarizes the advantages and challenges of bacteria and bacterial components in cancer therapy, outlines combinatorial strategies for nanocarriers and bacterial/bacterial components, and discusses their clinical applications.